Literature DB >> 19765409

Guidelines for the management of mucopolysaccharidosis type I.

Ana Maria Martins1, Ana Paula Dualibi, Denise Norato, Edna Tiemi Takata, Emerson S Santos, Eugênia Ribeiro Valadares, Gilda Porta, Gisele de Luca, Gustavo Moreira, Helena Pimentel, Janice Coelho, Jaime Moritz Brum, José Semionato Filho, Marcelo Soares Kerstenetzky, Márcia R Guimarães, Maria Verónica Muñoz Rojas, Paulo Cesar Aranda, Ricardo Flores Pires, Rodrigo G C Faria, Ronald Moura Vale Mota, Ursula Matte, Zelita Caldeira Ferreira Guedes.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19765409     DOI： 10.1016/j.jpeds.2009.07.005

Source DB:  PubMed          Journal:  J Pediatr        ISSN： 0022-3476            Impact factor:   4.406


× No keyword cloud information.
  36 in total

Review 1.  Lysosomal storage disease overview.

Authors:  Angela Sun
Journal:  Ann Transl Med       Date:  2018-12

2.  Plasmatic and Urinary Glycosaminoglycans Characterization in Mucopolysaccharidosis II Patient Treated with Enzyme-Replacement Therapy with Idursulfase.

Authors:  Giovanni V Coppa; Dania Buzzega; Lucia Zampini; Francesca Maccari; Lucia Santoro; Fabio Galeotti; Tiziana Galeazzi; Orazio Gabrielli; Nicola Volpi
Journal:  JIMD Rep       Date:  2011-11-04

Review 3.  Cell microencapsulation: a potential tool for the treatment of neuronopathic lysosomal storage diseases.

Authors:  Ursula Matte; Valeska Lizzi Lagranha; Talita Giacomet de Carvalho; Fabiana Quoos Mayer; Roberto Giugliani
Journal:  J Inherit Metab Dis       Date:  2011-05-26       Impact factor: 4.982

4.  Receiving enzyme replacement therapy for a lysosomal storage disorder: a preliminary exploration of the experiences of young patients and their families.

Authors:  R Freedman; M Sahhar; L Curnow; J Lee; H Peters
Journal:  J Genet Couns       Date:  2013-03-28       Impact factor: 2.537

Review 5.  Radiological and clinical characterization of the lysosomal storage disorders: non-lipid disorders.

Authors:  E I Parker; M Xing; A Moreno-De-Luca; E Harmouche; M R Terk
Journal:  Br J Radiol       Date:  2013-11-14       Impact factor: 3.039

6.  Relationship of sleep to pulmonary function in mucopolysaccharidosis II.

Authors:  William I Wooten; Joseph Muenzer; Bradley V Vaughn; Marianne S Muhlebach
Journal:  J Pediatr       Date:  2013-01-08       Impact factor: 4.406

7.  Prevalence of obstructive sleep apnea in patients with mucopolysaccharidosis types I, II, and VI in a reference center.

Authors:  Gustavo A Moreira; Sandra O Kyosen; Camilla L Patti; Ana Maria Martins; Sergio Tufik
Journal:  Sleep Breath       Date:  2014-04-05       Impact factor: 2.816

8.  Plasmatic kinetics of dermatan sulfate during enzyme replacement therapy with iduronate-2-sulfatase in a mucopolysaccharidosis II patient.

Authors:  Nicola Volpi; Lucia Zampini; Francesca Maccari; Lucia Santoro; Fabio Galeotti; Tiziana Galeazzi; Orazio Gabrielli; Giovanni V Coppa
Journal:  Glycoconj J       Date:  2013-03-20       Impact factor: 2.916

Review 9.  Orthopaedic management of Hurler's disease after hematopoietic stem cell transplantation: a systematic review.

Authors:  Marleen H van der Linden; Moyo C Kruyt; Ralph J B Sakkers; Tom J de Koning; F Cumhur Oner; René M Castelein
Journal:  J Inherit Metab Dis       Date:  2011-03-17       Impact factor: 4.982

Review 10.  Anaesthesia and airway management in mucopolysaccharidosis.

Authors:  Robert Walker; Kumar G Belani; Elizabeth A Braunlin; Iain A Bruce; Henrik Hack; Paul R Harmatz; Simon Jones; Richard Rowe; Guirish A Solanki; Barbara Valdemarsson
Journal:  J Inherit Metab Dis       Date:  2012-11-30       Impact factor: 4.982
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.